Lv1
59 积分 2023-04-24 加入
Pragmatic Clinical Perspective on Biologics for Severe Refractory Type 2 Asthma
2天前
已完结
Phenotypes and Emerging Endotypes of Chronic Rhinosinusitis
7天前
已完结
Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers
7天前
已完结
Comorbid Inducible Urticaria Is Linked to Non-Autoimmune Chronic Spontaneous Urticaria: CURE Insights
8天前
已完结
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
8天前
已完结
Prevalence of asthma in patients with atopic dermatitis: A systematic review and meta-analysis
8天前
已完结
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase
9天前
已完结
Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma
25天前
已完结
CD‐sens and clinical changes during withdrawal of Xolair after 6 years of treatment
25天前
已完结
Lung function parameters in omalizumab responder patients: An interesting tool?
25天前
已完结
皖公网安备34019202002308
